ANAVEX LIFE SCIENCES CORP. Payments to Acquire in Process Research and Development
ANAVEX LIFE SCIENCES CORP. (AVXL) reported Payments to Acquire in Process Research and Development of $4.19 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-08-28.
Financial Statements › Cash Flow
us-gaap:PaymentsToAcquireInProcessResearchAndDevelopment · last filed 2026-08-28
- ANAVEX LIFE SCIENCES CORP. payments to acquire in process research and development for the quarter ending 2026-03-31 was $4.19M, a 57.62% decline year-over-year.
- ANAVEX LIFE SCIENCES CORP. payments to acquire in process research and development for the quarter ending 2025-12-31 was $4.66M, a 55.43% decline year-over-year.
- ANAVEX LIFE SCIENCES CORP. payments to acquire in process research and development for the quarter ending 2025-03-31 was $9.89M.
- ANAVEX LIFE SCIENCES CORP. payments to acquire in process research and development for the quarter ending 2024-12-31 was $10.45M.
- ANAVEX LIFE SCIENCES CORP. payments to acquire in process research and development for fiscal 2025 was $37.59M, a 10.15% decline from fiscal 2024.
- ANAVEX LIFE SCIENCES CORP. payments to acquire in process research and development for fiscal 2024 was $41.84M, a 4.30% decline from fiscal 2023.
- ANAVEX LIFE SCIENCES CORP. payments to acquire in process research and development for fiscal 2023 was $43.72M.
| Period end | Payments to Acquire in Process Research and Development 3 month | Payments to Acquire in Process Research and Development 6 month | Payments to Acquire in Process Research and Development 12 month |
|---|---|---|---|
| 2026-03-31 | $4.19M 10-Q · filed 2026-08-28 | $8.85M 10-Q · filed 2026-08-28 | |
| 2025-12-31 | $4.66M 10-Q · filed 2026-02-09 | ||
| 2025-09-30 | $37.59M 10-K/A · filed 2026-08-28 | ||
| 2025-03-31 | $9.89M 10-Q · filed 2026-08-28 | $20.34M 10-Q · filed 2026-08-28 | |
| 2024-12-31 | $10.45M 10-Q · filed 2026-02-09 | ||
| 2024-09-30 | $41.84M 10-K/A · filed 2026-08-28 | ||
| 2023-09-30 | $43.72M 10-K/A · filed 2026-08-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |